BPC-157 is not approved by the FDA or any regulatory agency for human use
[PubMed Citation] Fujita Y, Fujino Y, Onodera M, Kikuchi S, Kikkawa T, Inoue Y, Niitsu H, Takahashi K, Endo S
GLP-1 receptor agonists caused thyroid C-cell tumors in rodent studies, and while human cases are rare, the FDA requires a black-box warning
To infiltrate the islet, T cells must trigger the cathepsin-mediated loss of peri-islet ECM to bypass the peri-islet membrane ( Figure 2 )
BPC-157 and TB-500 are combined into one formulation, allowing researchers to work with a stable, pre-blended research material rather than handling individual components separately
Gastric and intestinal protection is another major research area as a gastric-derived peptide, BPC-157 has been extensively explored for protective effects on the gastrointestinal lining